LIDOCAINE HCL

LIDOCAINE HCL was reported 2563 times

LIDOCAINE HCL is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ASPIRATION JOINT ABNORMAL 2 0.1000
1 LAGOPHTHALMOS 38 0.0929
2 PSEUDALLESCHERIA INFECTION 2 0.0714
3 LEVATOR SYNDROME 2 0.0513
4 MYOPATHY TOXIC 23 0.0372
5 APPLICATION SITE ALOPECIA 2 0.0364
6 SPINAL ANAESTHESIA 2 0.0260
7 BLOOD ETHANOL 1 0.0238
8 OCULAR RETROBULBAR HAEMORRHAGE 3 0.0216
9 CSF CULTURE POSITIVE 2 0.0189
10 BASE EXCESS NEGATIVE 1 0.0189
11 BASOSQUAMOUS CARCINOMA OF SKIN 1 0.0172
12 ARTERIOGRAM CORONARY ABNORMAL 1 0.0137
13 MYCOBACTERIUM CHELONAE INFECTION 10 0.0135
14 BARBITURATES POSITIVE 1 0.0125
15 BLOOD LACTATE DEHYDROGENASE 1 0.0123
16 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 13 0.0122
17 BRAIN NATRIURETIC PEPTIDE DECREASED 1 0.0119
18 ORBITAL OEDEMA 6 0.0119
19 DRUG INTERACTION POTENTIATION 3 0.0116
20 SEPTIC ARTHRITIS STAPHYLOCOCCAL 4 0.0115
21 BUNDLE BRANCH BLOCK BILATERAL 1 0.0104
22 ANAL POLYP 1 0.0097
23 VENTRICULAR TACHYARRHYTHMIA 3 0.0094
24 ANAESTHETIC COMPLICATION 25 0.0093
25 TOXIC ANTERIOR SEGMENT SYNDROME 10 0.0092
26 ANAL EROSION 1 0.0091
27 SPINAL CORD INFARCTION 4 0.0091
28 SUSPECTED PRODUCT CONTAMINATION 9 0.0089
29 ABDOMINAL WALL CYST 1 0.0082
30 CANDIDA ENDOPHTHALMITIS 1 0.0082
31 BALANITIS 1 0.0082
32 ANAL ERYTHEMA 1 0.0080
33 CAUDA EQUINA SYNDROME 6 0.0078
34 METHAEMOGLOBINAEMIA 18 0.0078
35 EMBOLIA CUTIS MEDICAMENTOSA 6 0.0075
36 UTERINE HYPERTONUS 2 0.0074
37 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 9 0.0072
38 SUDDEN VISUAL LOSS 2 0.0072
39 NERVE BLOCK 4 0.0068
40 CARBOHYDRATE ANTIGEN 27.29 INCREASED 1 0.0067
41 AIRWAY PEAK PRESSURE INCREASED 1 0.0066
42 ABSCESS SOFT TISSUE 1 0.0065
43 BLADDER SPHINCTER ATONY 1 0.0065
44 AORTIC VALVE THICKENING 1 0.0062
45 BRACHIAL PLEXUS INJURY 1 0.0062
46 ARTHRITIS INFECTIVE 28 0.0060
47 FAT EMBOLISM 2 0.0056
48 ADMINISTRATION RELATED REACTION 1 0.0051
49 EXTRADURAL ABSCESS 4 0.0051
50 ADULTERATED PRODUCT 1 0.0050
51 ARTHROSCOPIC SURGERY 1 0.0050
52 AMAUROSIS 4 0.0048
53 CAROTID ARTERY DISSECTION 2 0.0047
54 ATRIOVENTRICULAR DISSOCIATION 1 0.0047
55 AUTOIMMUNE MYOCARDITIS 1 0.0046
56 SEXUAL ABUSE 2 0.0045
57 OPERATIVE HAEMORRHAGE 2 0.0045
58 ANORECTAL SWELLING 1 0.0044
59 ALBUMIN GLOBULIN RATIO DECREASED 1 0.0043
60 SKIN TEST POSITIVE 4 0.0043
61 VEIN DISCOLOURATION 2 0.0043
62 CHONDROLYSIS 2 0.0043
63 OPEN FRACTURE 2 0.0041
64 METASTASES TO BONE MARROW 2 0.0040
65 CATHETER SITE RELATED REACTION 3 0.0040
66 TRANSPLANT EVALUATION 2 0.0039
67 AIRWAY COMPLICATION OF ANAESTHESIA 1 0.0038
68 REACTION TO PRESERVATIVES 3 0.0037
69 ATOPY 1 0.0036
70 PRODUCT CLOSURE ISSUE 2 0.0036
71 BODY TINEA 2 0.0036
72 CARBUNCLE 1 0.0035
73 VULVOVAGINAL INJURY 2 0.0035
74 ADMINISTRATION SITE ERYTHEMA 1 0.0035
75 HEAD BANGING 2 0.0035
76 IRREGULAR BREATHING 2 0.0034
77 ENDOTRACHEAL INTUBATION COMPLICATION 2 0.0034
78 CANDIDA SEPSIS 3 0.0033
79 BUTTOCK INJURY 1 0.0033
80 CORNEAL PERFORATION 2 0.0032
81 OPHTHALMOPLEGIA 5 0.0032
82 SUBCUTANEOUS EMPHYSEMA 3 0.0031
83 ALOPECIA TOTALIS 1 0.0030
84 PRODUCT MEASURED POTENCY ISSUE 3 0.0030
85 BILIARY CIRRHOSIS PRIMARY 1 0.0029
86 ASTHMA EXERCISE INDUCED 1 0.0029
87 ANION GAP DECREASED 1 0.0029
88 CATAPLEXY 4 0.0028
89 ACQUIRED DIAPHRAGMATIC EVENTRATION 1 0.0028
90 MYCOBACTERIUM ABSCESSUS INFECTION 2 0.0028
91 RETINAL ARTERY OCCLUSION 7 0.0028
92 FOREIGN BODY TRAUMA 2 0.0027
93 RESPIRATORY TRACT OEDEMA 2 0.0027
94 HYPERTHERMIA MALIGNANT 4 0.0027
95 ARTHRITIS BACTERIAL 11 0.0027
96 BRAIN STEM SYNDROME 2 0.0027
97 BRONCHOPLEURAL FISTULA 1 0.0027
98 ALBUMIN URINE PRESENT 1 0.0026
99 BREATH HOLDING 1 0.0026
100 ADMINISTRATION SITE REACTION 1 0.0026
101 CHONDROCALCINOSIS PYROPHOSPHATE 2 0.0026
102 FUNGAEMIA 4 0.0025
103 OPISTHOTONUS 2 0.0025
104 RECTAL PROLAPSE 3 0.0025
105 AMMONIA ABNORMAL 1 0.0025
106 PSEUDOMONAS TEST POSITIVE 2 0.0024
107 PERIORBITAL HAEMATOMA 2 0.0024
108 ANTEPARTUM HAEMORRHAGE 1 0.0024
109 BRADYCARDIA FOETAL 2 0.0024
110 ANAL SPHINCTER ATONY 1 0.0023
111 POOR QUALITY DRUG ADMINISTERED 15 0.0023
112 RELAPSING-REMITTING MULTIPLE SCLEROSIS 2 0.0023
113 VASOCONSTRICTION 2 0.0023
114 CATHETER SITE PRURITUS 2 0.0023
115 PRE-EXISTING CONDITION IMPROVED 14 0.0022
116 CATHETER MANAGEMENT 2 0.0022
117 ANAESTHETIC COMPLICATION NEUROLOGICAL 2 0.0022
118 ALLERGY TO ARTHROPOD STING 1 0.0022
119 PUPILLARY REFLEX IMPAIRED 4 0.0022
120 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
121 BIOPSY BONE MARROW 1 0.0021
122 INJECTION SITE ULCER 2 0.0021
123 ABSCESS LIMB 9 0.0021
124 MATERNAL EXPOSURE DURING DELIVERY 2 0.0020
125 ONYCHALGIA 2 0.0020
126 FALSE POSITIVE INVESTIGATION RESULT 2 0.0020
127 PRODUCT CONTAMINATION PHYSICAL 5 0.0020
128 PRODUCT CONTAMINATION 7 0.0020
129 INHIBITORY DRUG INTERACTION 3 0.0019
130 OPTIC NERVE DISORDER 3 0.0019
131 AMAUROSIS FUGAX 2 0.0019
132 OPTIC ATROPHY 3 0.0018
133 GASTROINTESTINAL TRACT IRRITATION 2 0.0018
134 PROCEDURAL COMPLICATION 14 0.0018
135 BLOOD PH INCREASED 1 0.0018
136 INJECTION SITE INFLAMMATION 9 0.0018
137 PERIRECTAL ABSCESS 2 0.0018
138 FACIAL SPASM 2 0.0018
139 CORNEAL OEDEMA 4 0.0018
140 CATHETER SITE DISCHARGE 2 0.0018
141 APNOEIC ATTACK 1 0.0018
142 BURNING MOUTH SYNDROME 1 0.0018
143 FOREIGN BODY 7 0.0017
144 PALMAR ERYTHEMA 2 0.0017
145 ALLODYNIA 2 0.0017
146 BLOOD BILIRUBIN DECREASED 1 0.0016
147 FRACTURED SACRUM 2 0.0016
148 NEUTROPHIL PERCENTAGE INCREASED 2 0.0016
149 CONVERSION DISORDER 3 0.0015
150 C-REACTIVE PROTEIN DECREASED 1 0.0015
151 TUMOUR PAIN 2 0.0015
152 NYSTAGMUS 8 0.0015
153 ANORECTAL DISORDER 3 0.0015
154 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 2 0.0015
155 GENERALISED TONIC-CLONIC SEIZURE 24 0.0014
156 ARACHNOIDITIS 1 0.0014
157 JOINT INSTABILITY 2 0.0014
158 BLOOD OESTROGEN DECREASED 1 0.0014
159 MYELITIS TRANSVERSE 2 0.0014
160 ANTERIOR CHAMBER CELL 1 0.0014
161 TRACHEOSTOMY 2 0.0014
162 INJECTION SITE HYPOAESTHESIA 2 0.0014
163 ACCOMMODATION DISORDER 1 0.0014
164 NEUROTOXICITY 24 0.0014
165 NODAL RHYTHM 2 0.0014
166 AORTIC VALVE SCLEROSIS 1 0.0014
167 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
168 ARTERIAL INJURY 1 0.0013
169 CARBOHYDRATE ANTIGEN 15-3 INCREASED 1 0.0013
170 RESPIRATORY ACIDOSIS 5 0.0013
171 VENTRICULAR TACHYCARDIA 21 0.0013
172 NASAL ULCER 2 0.0013
173 VASOPLEGIA SYNDROME 2 0.0012
174 INJECTION SITE INFECTION 4 0.0012
175 MEAN CELL HAEMOGLOBIN INCREASED 2 0.0012
176 SEDATION COMPLICATION 3 0.0012
177 ANGLE CLOSURE GLAUCOMA 3 0.0012
178 ALLERGIC SINUSITIS 1 0.0012
179 RESPIRATORY ARREST 32 0.0012
180 PAPILLARY THYROID CANCER 2 0.0011
181 BURNS SECOND DEGREE 2 0.0011
182 ALOPECIA AREATA 2 0.0011
183 SINUS TACHYCARDIA 16 0.0011
184 AREFLEXIA 3 0.0011
185 LARYNGOSPASM 3 0.0011
186 ARTERIOVENOUS MALFORMATION 1 0.0011
187 TYPE IV HYPERSENSITIVITY REACTION 3 0.0011
188 GRAND MAL CONVULSION 10 0.0011
189 VENTRICULAR FIBRILLATION 12 0.0011
190 ACCIDENTAL DEATH 2 0.0011
191 HYPERCOAGULATION 2 0.0010
192 PRODUCT CONTAINER ISSUE 9 0.0010
193 PARAPLEGIA 3 0.0010
194 STRESS CARDIOMYOPATHY 6 0.0010
195 NASAL SEPTUM DEVIATION 2 0.0010
196 DIPLEGIA 2 0.0010
197 VEIN DISORDER 5 0.0010
198 ARTHRODESIS 1 0.0010
199 BRUGADA SYNDROME 1 0.0010
200 BONE MARROW OEDEMA 1 0.0010
201 ATRIAL TACHYCARDIA 2 0.0010
202 ASTERIXIS 1 0.0009
203 CATHETER SITE ERYTHEMA 2 0.0009
204 VENTRICULAR HYPOKINESIA 3 0.0009
205 ACINETOBACTER INFECTION 1 0.0009
206 INFECTION SUSCEPTIBILITY INCREASED 2 0.0009
207 CEREBELLAR SYNDROME 2 0.0009
208 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
209 ACCIDENT AT WORK 2 0.0009
210 APNOEA 7 0.0009
211 MENINGITIS 6 0.0009
212 PRODUCT PACKAGE ASSOCIATED INJURY 2 0.0009
213 SPINAL COLUMN INJURY 2 0.0009
214 JOINT RANGE OF MOTION DECREASED 12 0.0009
215 EYELID PTOSIS 9 0.0009
216 CARBON DIOXIDE DECREASED 1 0.0009
217 MYDRIASIS 11 0.0009
218 UNRESPONSIVE TO STIMULI 22 0.0009
219 INGROWING NAIL 2 0.0008
220 PULSE ABSENT 4 0.0008
221 URINARY HESITATION 2 0.0008
222 BRONCHIAL HYPERREACTIVITY 1 0.0008
223 CARDIAC ARREST 68 0.0008
224 CIRCULATORY COLLAPSE 14 0.0008
225 VENTRICULAR ARRHYTHMIA 3 0.0008
226 BLADDER PROLAPSE 1 0.0008
227 MULTIPLE DRUG OVERDOSE 4 0.0008
228 BLOOD UREA DECREASED 1 0.0008
229 CHRONIC SINUSITIS 3 0.0008
230 HYPOAESTHESIA ORAL 12 0.0008
231 STAPHYLOCOCCAL INFECTION 26 0.0008
232 CARDIOTOXICITY 7 0.0008
233 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 4 0.0008
234 BLOOD CHLORIDE DECREASED 2 0.0008
235 DRUG TITRATION ERROR 2 0.0008
236 CATHETER SITE PAIN 2 0.0008
237 VENTRICULAR EXTRASYSTOLES 8 0.0008
238 ABDOMINAL OPERATION 1 0.0008
239 ADJUSTMENT DISORDER 1 0.0008
240 COMPARTMENT SYNDROME 2 0.0008
241 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
242 CYANOSIS 12 0.0008
243 ACROCHORDON 1 0.0008
244 STEATORRHOEA 2 0.0007
245 SENSORY LOSS 6 0.0007
246 LACERATION 7 0.0007
247 ANAPHYLACTIC REACTION 41 0.0007
248 BLOOD SODIUM INCREASED 2 0.0007
249 CHONDROPATHY 2 0.0007
250 MIGRAINE WITH AURA 2 0.0007
251 DRUG TOXICITY 10 0.0007
252 CALCULUS BLADDER 1 0.0007
253 BRONCHIAL OBSTRUCTION 1 0.0007
254 IMMUNE THROMBOCYTOPENIC PURPURA 2 0.0007
255 AORTIC VALVE INCOMPETENCE 3 0.0007
256 AUDITORY DISORDER 1 0.0007
257 DYSPNOEA AT REST 2 0.0007
258 HYPERVENTILATION 4 0.0007
259 MOTOR DYSFUNCTION 7 0.0007
260 CREPITATIONS 2 0.0007
261 BRAIN HERNIATION 2 0.0007
262 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
263 BLOOD PRESSURE SYSTOLIC DECREASED 3 0.0007
264 KERATITIS 2 0.0007
265 BLOOD PRESSURE IMMEASURABLE 1 0.0007
266 RESPIRATORY DEPRESSION 8 0.0007
267 PORTAL HYPERTENSION 2 0.0006
268 BLOOD PROLACTIN INCREASED 3 0.0006
269 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
270 BLADDER PAIN 2 0.0006
271 OBSTRUCTIVE AIRWAYS DISORDER 7 0.0006
272 SLEEP APNOEA SYNDROME 12 0.0006
273 PARALYSIS 9 0.0006
274 SUPRAVENTRICULAR TACHYCARDIA 6 0.0006
275 ANTIPHOSPHOLIPID SYNDROME 1 0.0006
276 LYMPHOCYTE COUNT INCREASED 2 0.0006
277 SKIN INJURY 2 0.0006
278 HYPERNATRAEMIA 3 0.0006
279 ARTHROPOD STING 1 0.0006
280 NEPHRITIS 2 0.0006
281 PLANTAR FASCIITIS 2 0.0006
282 METASTASES TO SPINE 2 0.0006
283 BILIARY DYSKINESIA 1 0.0006
284 ENDOCARDITIS 3 0.0006
285 ACUTE SINUSITIS 1 0.0006
286 LYMPHOEDEMA 4 0.0006
287 EXTRASYSTOLES 4 0.0006
288 POST PROCEDURAL COMPLICATION 11 0.0006
289 CAROTID ARTERY STENOSIS 2 0.0006
290 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
291 RETINAL HAEMORRHAGE 4 0.0006
292 BRONCHOSPASM 8 0.0006
293 APPARENT DEATH 2 0.0006
294 MONOCYTE COUNT INCREASED 2 0.0006
295 HYPERKERATOSIS 3 0.0005
296 NERVE INJURY 6 0.0005
297 HYPERACUSIS 2 0.0005
298 TOXICITY TO VARIOUS AGENTS 90 0.0005
299 PROTEIN TOTAL DECREASED 2 0.0005
300 PERONEAL NERVE PALSY 3 0.0005
301 BONE MARROW TRANSPLANT 1 0.0005
302 HAEMODYNAMIC INSTABILITY 4 0.0005
303 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
304 CAESAREAN SECTION 6 0.0005
305 CERVIX CARCINOMA 2 0.0005
306 PROCEDURAL HAEMORRHAGE 2 0.0005
307 MULTIPLE ALLERGIES 4 0.0005
308 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
309 DRUG SCREEN POSITIVE 4 0.0005
310 BACTERAEMIA 6 0.0005
311 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
312 AZOTAEMIA 2 0.0005
313 ARTERIOSPASM CORONARY 2 0.0005
314 TRIGEMINAL NEURALGIA 2 0.0005
315 ENURESIS 2 0.0005
316 MUSCLE TIGHTNESS 8 0.0005
317 BRADYCARDIA 26 0.0005
318 LARYNGEAL OEDEMA 3 0.0005
319 ANAPHYLACTOID REACTION 2 0.0005
320 ANAL PRURITUS 1 0.0005
321 THYROID FUNCTION TEST ABNORMAL 2 0.0005
322 DYSARTHRIA 18 0.0005
323 SELF-INJURIOUS IDEATION 2 0.0005
324 INCORRECT DRUG ADMINISTRATION RATE 2 0.0005
325 SHOULDER OPERATION 2 0.0005
326 ACUTE MYELOID LEUKAEMIA RECURRENT 1 0.0005
327 BLOOD MAGNESIUM DECREASED 4 0.0005
328 SOMNAMBULISM 3 0.0005
329 ASPERGILLUS INFECTION 3 0.0005
330 HAEMORRHAGIC ANAEMIA 2 0.0005
331 VULVOVAGINAL DISCOMFORT 2 0.0005
332 ABDOMINAL ABSCESS 2 0.0005
333 WRONG DRUG ADMINISTERED 4 0.0004
334 BACTERIAL TEST POSITIVE 1 0.0004
335 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
336 PALLOR 12 0.0004
337 URINE ABNORMALITY 2 0.0004
338 RESPIRATION ABNORMAL 3 0.0004
339 APHTHOUS STOMATITIS 1 0.0004
340 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
341 NEPHROGENIC ANAEMIA 2 0.0004
342 RENAL FUNCTION TEST ABNORMAL 2 0.0004
343 ANAPHYLACTIC SHOCK 11 0.0004
344 DUODENAL ULCER 3 0.0004
345 CARDIAC TAMPONADE 2 0.0004
346 MYOCLONUS 5 0.0004
347 MUSCLE RIGIDITY 5 0.0004
348 PARAESTHESIA ORAL 6 0.0004
349 RASH VESICULAR 2 0.0004
350 INTERVERTEBRAL DISC PROTRUSION 9 0.0004
351 BLINDNESS TRANSIENT 3 0.0004
352 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
353 ACUTE PSYCHOSIS 1 0.0004
354 DIABETIC NEUROPATHY 2 0.0004
355 ABDOMINAL INFECTION 1 0.0004
356 MUSCLE TWITCHING 9 0.0004
357 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
358 TRISMUS 2 0.0004
359 SKIN NECROSIS 2 0.0004
360 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
361 BURNING SENSATION 27 0.0004
362 PARTIAL SEIZURES 2 0.0004
363 ABSCESS 6 0.0004
364 BLOOD POTASSIUM ABNORMAL 1 0.0004
365 BRADYPNOEA 1 0.0004
366 MUSCULAR WEAKNESS 42 0.0004
367 SUBSTANCE ABUSE 3 0.0004
368 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
369 CONVULSION 21 0.0004
370 INCORRECT ROUTE OF DRUG ADMINISTRATION 13 0.0004
371 DEAFNESS UNILATERAL 2 0.0004
372 LOSS OF CONSCIOUSNESS 46 0.0004
373 LIVE BIRTH 3 0.0004
374 ANAL HAEMORRHAGE 1 0.0004
375 STATUS EPILEPTICUS 4 0.0004
376 FACIAL PARALYSIS 3 0.0004
377 GENERALISED ERYTHEMA 2 0.0004
378 MICTURITION URGENCY 4 0.0003
379 SKIN HYPERPIGMENTATION 3 0.0003
380 DIPLOPIA 9 0.0003
381 ADENOVIRUS INFECTION 1 0.0003
382 PRODUCT LABEL CONFUSION 2 0.0003
383 SPINAL PAIN 4 0.0003
384 SURGERY 20 0.0003
385 URINARY INCONTINENCE 10 0.0003
386 CELLULITIS 17 0.0003
387 ATAXIA 4 0.0003
388 MYOSITIS 3 0.0003
389 THERAPEUTIC RESPONSE UNEXPECTED 15 0.0003
390 ANAL INCONTINENCE 3 0.0003
391 APHASIA 10 0.0003
392 GAIT INABILITY 11 0.0003
393 NEURALGIA 8 0.0003
394 SEIZURE 38 0.0003
395 EXOSTOSIS 3 0.0003
396 TENSION 2 0.0003
397 NERVE COMPRESSION 3 0.0003
398 PHARYNGEAL OEDEMA 5 0.0003
399 DELUSION 5 0.0003
400 BACTERIAL INFECTION 6 0.0003
401 FLANK PAIN 3 0.0003
402 BLOOD CREATININE DECREASED 1 0.0003
403 POISONING 4 0.0003
404 MULTIPLE INJURIES 2 0.0003
405 RECALLED PRODUCT ADMINISTERED 3 0.0003
406 EYE INFLAMMATION 3 0.0003
407 HYPOXIA 11 0.0003
408 DRUG INEFFECTIVE 411 0.0003
409 SINUS BRADYCARDIA 3 0.0003
410 PRODUCT QUALITY ISSUE 42 0.0003
411 BODY TEMPERATURE DECREASED 3 0.0003
412 BLADDER DISORDER 3 0.0003
413 DRUG LEVEL INCREASED 5 0.0003
414 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
415 BLOOD PRESSURE ABNORMAL 6 0.0003
416 APPETITE DISORDER 2 0.0003
417 ACCIDENTAL OVERDOSE 11 0.0003
418 HYPOAESTHESIA 45 0.0003
419 HYPOTONIA 3 0.0003
420 BRAIN INJURY 3 0.0003
421 SWELLING 28 0.0003
422 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
423 DRUG EFFECT DECREASED 16 0.0003
424 PRODUCT LABEL ISSUE 2 0.0003
425 BLINDNESS 12 0.0003
426 HYPOTENSION 59 0.0003
427 IMPAIRED GASTRIC EMPTYING 4 0.0003
428 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
429 EYE MOVEMENT DISORDER 2 0.0003
430 APLASIA PURE RED CELL 1 0.0003
431 JOINT EFFUSION 2 0.0003
432 DROOLING 2 0.0003
433 PRESYNCOPE 7 0.0003
434 TENDERNESS 3 0.0003
435 CARDIO-RESPIRATORY ARREST 12 0.0003
436 INCONTINENCE 3 0.0003
437 TINNITUS 13 0.0003
438 BONE EROSION 1 0.0003
439 THERMAL BURN 2 0.0003
440 BONE LESION 1 0.0003
441 PANIC REACTION 2 0.0003
442 VISUAL FIELD DEFECT 2 0.0003
443 OSTEOMYELITIS 5 0.0003
444 SKIN LACERATION 3 0.0003
445 DRUG EFFECT INCOMPLETE 10 0.0003
446 DEVICE BREAKAGE 11 0.0003
447 SKIN ULCER 7 0.0003
448 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
449 HAEMATOMA 7 0.0003
450 TACHYCARDIA 24 0.0003
451 ARTHROPATHY 15 0.0003
452 ORAL PAIN 6 0.0003
453 BONE DENSITY ABNORMAL 1 0.0003
454 BLOOD CALCIUM DECREASED 3 0.0003
455 EYE INFECTION 3 0.0003
456 DERMATITIS CONTACT 3 0.0003
457 DEVICE FAILURE 4 0.0003
458 MUSCULOSKELETAL DISORDER 5 0.0003
459 DEVICE PHYSICAL PROPERTY ISSUE 2 0.0003
460 SHOCK 6 0.0003
461 FOOD ALLERGY 2 0.0003
462 AGITATION 19 0.0003
463 MADAROSIS 3 0.0003
464 PRESCRIBED OVERDOSE 5 0.0003
465 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
466 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
467 TORSADE DE POINTES 2 0.0003
468 HAEMATOCRIT DECREASED 5 0.0003
469 TRICUSPID VALVE INCOMPETENCE 2 0.0003
470 ACCIDENT 3 0.0003
471 MIOSIS 2 0.0002
472 BURSITIS 3 0.0002
473 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7 0.0002
474 DYSKINESIA 10 0.0002
475 BACK DISORDER 4 0.0002
476 DRUG INTERACTION 39 0.0002
477 BODY TEMPERATURE INCREASED 5 0.0002
478 POLYURIA 2 0.0002
479 MUSCLE SPASTICITY 3 0.0002
480 HYPERAESTHESIA 2 0.0002
481 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
482 ACCIDENTAL EXPOSURE 1 0.0002
483 FUNGAL INFECTION 8 0.0002
484 EOSINOPHIL COUNT INCREASED 2 0.0002
485 PRODUCT USE ISSUE 45 0.0002
486 CANDIDA INFECTION 4 0.0002
487 HALLUCINATION, VISUAL 5 0.0002
488 HEMIPARESIS 4 0.0002
489 BUNDLE BRANCH BLOCK LEFT 1 0.0002
490 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
491 VITAMIN D DECREASED 2 0.0002
492 IMPAIRED WORK ABILITY 5 0.0002
493 MEDICATION ERROR 13 0.0002
494 MUSCULOSKELETAL DISCOMFORT 4 0.0002
495 POOR QUALITY SLEEP 5 0.0002
496 PARANOIA 4 0.0002
497 ATRIOVENTRICULAR BLOCK FIRST DEGREE 1 0.0002
498 MUSCULOSKELETAL PAIN 12 0.0002
499 INCORRECT PRODUCT STORAGE 3 0.0002
500 GROIN PAIN 2 0.0002
501 GRIP STRENGTH DECREASED 2 0.0002
502 ADVERSE REACTION 3 0.0002
503 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
504 ACUTE RESPIRATORY DISTRESS SYNDROME 4 0.0002
505 PURPURA 2 0.0002
506 HEAD DISCOMFORT 4 0.0002
507 RESPIRATORY RATE INCREASED 2 0.0002
508 BRAIN NEOPLASM MALIGNANT 1 0.0002
509 TACHYPNOEA 3 0.0002
510 CYSTITIS 7 0.0002
511 END STAGE RENAL DISEASE 4 0.0002
512 RESTLESSNESS 8 0.0002
513 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
514 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
515 ORAL DISCOMFORT 3 0.0002
516 SEPSIS 24 0.0002
517 MASS 3 0.0002
518 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 5 0.0002
519 BLINDNESS UNILATERAL 3 0.0002
520 OSTEOARTHRITIS 9 0.0002
521 FOOT FRACTURE 4 0.0002
522 PRODUCT PACKAGING ISSUE 2 0.0002
523 RED BLOOD CELL COUNT DECREASED 6 0.0002
524 AFFECT LABILITY 2 0.0002
525 APHAGIA 1 0.0002
526 FIBROMYALGIA 5 0.0002
527 AUTOIMMUNE DISORDER 2 0.0002
528 PAIN 126 0.0002
529 VITAMIN D DEFICIENCY 2 0.0002
530 CHOKING 4 0.0002
531 DRUG ABUSE 17 0.0002
532 HEPATOMEGALY 2 0.0002
533 APPLICATION SITE BURN 1 0.0002
534 CARDIOMYOPATHY 3 0.0002
535 BREATH SOUNDS ABNORMAL 1 0.0002
536 DISABILITY 4 0.0002
537 DISORIENTATION 8 0.0002
538 DELIRIUM 7 0.0002
539 SALIVARY HYPERSECRETION 2 0.0002
540 NEUROPATHY PERIPHERAL 19 0.0002
541 OVERDOSE 43 0.0002
542 FULL BLOOD COUNT DECREASED 4 0.0002
543 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
544 VERTIGO 12 0.0002
545 TOOTH ABSCESS 2 0.0002
546 PALPITATIONS 23 0.0002
547 DRUG DISPENSING ERROR 3 0.0002
548 NEUTROPHIL COUNT INCREASED 2 0.0002
549 EUPHORIC MOOD 2 0.0002
550 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
551 LYMPHOMA 3 0.0002
552 INFLAMMATION 10 0.0002
553 EJECTION FRACTION DECREASED 3 0.0002
554 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
555 NERVOUS SYSTEM DISORDER 6 0.0002
556 PANIC ATTACK 7 0.0002
557 SEDATION 5 0.0002
558 DERMATITIS 4 0.0002
559 FOLLICULITIS 2 0.0002
560 SYNCOPE 19 0.0002
561 JOINT DISLOCATION 2 0.0002
562 PNEUMOTHORAX 3 0.0002
563 HYPERTENSION 40 0.0002
564 RESPIRATORY TRACT CONGESTION 3 0.0002
565 HALLUCINATION, AUDITORY 3 0.0002
566 ANORECTAL DISCOMFORT 1 0.0002
567 EAR INFECTION 5 0.0002
568 METABOLIC ACIDOSIS 6 0.0002
569 ANAL FISTULA 1 0.0002
570 IRRITABLE BOWEL SYNDROME 4 0.0002
571 ANAL FISSURE 1 0.0002
572 NIGHT SWEATS 6 0.0002
573 ANAL ABSCESS 1 0.0002
574 BLOOD BILIRUBIN INCREASED 5 0.0002
575 OESOPHAGITIS 2 0.0002
576 IMPAIRED HEALING 6 0.0002
577 DENTAL CARIES 2 0.0002
578 BLOOD PRESSURE DECREASED 12 0.0002
579 MENTAL STATUS CHANGES 5 0.0002
580 TRANSAMINASES INCREASED 4 0.0002
581 SKIN DISORDER 6 0.0002
582 TOOTH DISORDER 4 0.0002
583 FEELING COLD 5 0.0002
584 BLOOD UREA INCREASED 3 0.0002
585 ANGIOPATHY 1 0.0002
586 ACUTE PULMONARY OEDEMA 1 0.0002
587 NO ADVERSE EVENT 32 0.0002
588 CHOLECYSTECTOMY 2 0.0002
589 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
590 DYSGEUSIA 13 0.0002
591 TREMOR 29 0.0002
592 SKIN DISCOLOURATION 8 0.0002
593 LETHARGY 10 0.0002
594 EPISTAXIS 13 0.0002
595 MULTI-ORGAN FAILURE 3 0.0002
596 INJECTION SITE PAIN 53 0.0002
597 HYPERSENSITIVITY 32 0.0002
598 EYELID OEDEMA 2 0.0002
599 LOCAL SWELLING 3 0.0002
600 UNEVALUABLE EVENT 13 0.0002
601 SPEECH DISORDER 9 0.0002
602 VASCULITIS 2 0.0002
603 PARAESTHESIA 27 0.0002
604 HEART RATE INCREASED 17 0.0002
605 HEART RATE DECREASED 6 0.0002
606 LYMPHOCYTE COUNT DECREASED 3 0.0002
607 INJECTION SITE SWELLING 13 0.0002
608 WHEEZING 10 0.0002
609 RHABDOMYOLYSIS 7 0.0002
610 HYPERLIPIDAEMIA 2 0.0002
611 DISTURBANCE IN ATTENTION 9 0.0002
612 WRIST FRACTURE 2 0.0002
613 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
614 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
615 GASTROENTERITIS VIRAL 3 0.0002
616 PREMATURE BABY 5 0.0002
617 LOCALISED INFECTION 4 0.0002
618 CRYING 6 0.0002
619 MENTAL IMPAIRMENT 4 0.0002
620 RESPIRATORY FAILURE 12 0.0002
621 ATRIAL FIBRILLATION 16 0.0002
622 NO THERAPEUTIC RESPONSE 2 0.0002
623 DISCOMFORT 10 0.0002
624 BLOOD PRESSURE INCREASED 25 0.0002
625 FEELING ABNORMAL 39 0.0002
626 CARDIOMEGALY 2 0.0002
627 BLOOD GLUCOSE ABNORMAL 3 0.0002
628 HYPERCALCAEMIA 2 0.0002
629 ABASIA 4 0.0002
630 URTICARIA 27 0.0002
631 HAIR COLOUR CHANGES 2 0.0002
632 TOOTH EXTRACTION 2 0.0002
633 MIDDLE INSOMNIA 3 0.0002
634 OXYGEN SATURATION DECREASED 9 0.0002
635 PNEUMONIA ASPIRATION 4 0.0002
636 SWOLLEN TONGUE 5 0.0002
637 BONE DENSITY DECREASED 5 0.0002
638 PHOTOPHOBIA 3 0.0002
639 BLOOD SODIUM DECREASED 3 0.0002
640 DERMATITIS ALLERGIC 2 0.0002
641 INFECTION 23 0.0002
642 MUSCLE ATROPHY 2 0.0002
643 JOINT SWELLING 19 0.0002
644 PLASMA CELL MYELOMA 6 0.0002
645 ORAL HERPES 3 0.0002
646 BONE PAIN 9 0.0002
647 BRADYPHRENIA 1 0.0002
648 MUCOSAL INFLAMMATION 4 0.0002
649 ORAL CANDIDIASIS 2 0.0002
650 IMMUNE SYSTEM DISORDER 2 0.0002
651 ANKYLOSING SPONDYLITIS 2 0.0002
652 PULMONARY CONGESTION 2 0.0002
653 BALANCE DISORDER 13 0.0002
654 BLOOD CHOLESTEROL INCREASED 7 0.0002
655 EYE HAEMORRHAGE 2 0.0001
656 SOMNOLENCE 30 0.0001
657 STOMATITIS 9 0.0001
658 THROAT TIGHTNESS 4 0.0001
659 TASTE DISORDER 3 0.0001
660 COMA 7 0.0001
661 ABNORMAL LOSS OF WEIGHT 1 0.0001
662 PRODUCTIVE COUGH 7 0.0001
663 SINUSITIS 15 0.0001
664 BLOOD TESTOSTERONE DECREASED 1 0.0001
665 PRODUCT PREPARATION ERROR 3 0.0001
666 PERIPHERAL COLDNESS 2 0.0001
667 EXPOSURE DURING PREGNANCY 9 0.0001
668 CHRONIC KIDNEY DISEASE 11 0.0001
669 NIGHTMARE 5 0.0001
670 PROCEDURAL PAIN 4 0.0001
671 HUNGER 2 0.0001
672 HAEMOPTYSIS 4 0.0001
673 COORDINATION ABNORMAL 2 0.0001
674 APHONIA 2 0.0001
675 NECK PAIN 8 0.0001
676 BLISTER 8 0.0001
677 RENAL FAILURE ACUTE 6 0.0001
678 PAIN IN JAW 4 0.0001
679 SYSTEMIC LUPUS ERYTHEMATOSUS 5 0.0001
680 IMPAIRED QUALITY OF LIFE 2 0.0001
681 INJECTION SITE HAEMATOMA 2 0.0001
682 FLUSHING 14 0.0001
683 FLUID OVERLOAD 2 0.0001
684 DYSSTASIA 4 0.0001
685 CHEST DISCOMFORT 14 0.0001
686 ACUTE MYOCARDIAL INFARCTION 4 0.0001
687 EYE SWELLING 5 0.0001
688 CATARACT 8 0.0001
689 DIZZINESS 67 0.0001
690 IMMUNODEFICIENCY 2 0.0001
691 PULMONARY OEDEMA 6 0.0001
692 RASH PAPULAR 3 0.0001
693 HAEMORRHAGE INTRACRANIAL 2 0.0001
694 RESPIRATORY DISORDER 4 0.0001
695 BLOOD POTASSIUM DECREASED 4 0.0001
696 HOT FLUSH 10 0.0001
697 DYSPEPSIA 13 0.0001
698 ECONOMIC PROBLEM 2 0.0001
699 BLOOD COUNT ABNORMAL 2 0.0001
700 OSTEOPENIA 2 0.0001
701 ERYTHEMA 27 0.0001
702 DIABETES MELLITUS 10 0.0001
703 ACIDOSIS 1 0.0001
704 HIP ARTHROPLASTY 2 0.0001
705 BOWEL MOVEMENT IRREGULARITY 1 0.0001
706 DRUG ADMINISTRATION ERROR 4 0.0001
707 PYREXIA 45 0.0001
708 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
709 ANKLE FRACTURE 2 0.0001
710 OEDEMA 7 0.0001
711 LUNG INFECTION 2 0.0001
712 COGNITIVE DISORDER 6 0.0001
713 CARDIAC DISORDER 12 0.0001
714 SLEEP DISORDER 9 0.0001
715 ARTHRALGIA 53 0.0001
716 DEHYDRATION 17 0.0001
717 ARRHYTHMIA 6 0.0001
718 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
719 ABNORMAL BEHAVIOUR 5 0.0001
720 RASH 55 0.0001
721 BLOOD ALBUMIN DECREASED 1 0.0001
722 PREMATURE DELIVERY 2 0.0001
723 SCIATICA 2 0.0001
724 CONDITION AGGRAVATED 38 0.0001
725 CONTUSION 12 0.0001
726 DRUG INTOLERANCE 12 0.0001
727 FLATULENCE 7 0.0001
728 MATERNAL EXPOSURE DURING PREGNANCY 11 0.0001
729 CEREBRAL INFARCTION 3 0.0001
730 EYE DISORDER 4 0.0001
731 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
732 ACUTE CORONARY SYNDROME 1 0.0001
733 RENAL FAILURE 16 0.0001
734 EXPIRED PRODUCT ADMINISTERED 4 0.0001
735 LIP SWELLING 4 0.0001
736 MUSCLE SPASMS 22 0.0001
737 AGGRESSION 6 0.0001
738 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
739 FACE OEDEMA 2 0.0001
740 PRODUCT USE IN UNAPPROVED INDICATION 29 0.0001
741 ERECTILE DYSFUNCTION 3 0.0001
742 HYPERHIDROSIS 15 0.0001
743 HYPOACUSIS 5 0.0001
744 RASH GENERALISED 3 0.0001
745 ASTHMA 13 0.0001
746 DEAFNESS 3 0.0001
747 RASH MACULAR 4 0.0001
748 ANHEDONIA 3 0.0001
749 BLOOD CALCIUM INCREASED 1 0.0001
750 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
751 GALLBLADDER DISORDER 2 0.0001
752 PAIN IN EXTREMITY 33 0.0001
753 THROAT IRRITATION 5 0.0001
754 CONFUSIONAL STATE 18 0.0001
755 SYNOVITIS 2 0.0001
756 PERIPHERAL SWELLING 17 0.0001
757 MOOD ALTERED 3 0.0001
758 VISION BLURRED 15 0.0001
759 DYSPNOEA 61 0.0001
760 BACK PAIN 25 0.0001
761 SWELLING FACE 7 0.0001
762 DEMENTIA 3 0.0001
763 THINKING ABNORMAL 2 0.0001
764 WOUND 3 0.0001
765 BLOOD CREATININE INCREASED 7 0.0001
766 ARTERIOSCLEROSIS 1 0.0001
767 DYSPNOEA EXERTIONAL 4 0.0001
768 GASTRIC ULCER 2 0.0001
769 DISEASE RECURRENCE 5 0.0001
770 FEELING JITTERY 2 0.0001
771 ANGINA PECTORIS 3 0.0001
772 HERPES ZOSTER 6 0.0001
773 PULMONARY FIBROSIS 2 0.0001
774 CHOLESTASIS 2 0.0001
775 DRUG PRESCRIBING ERROR 2 0.0001
776 ACUTE RESPIRATORY FAILURE 2 0.0001
777 LIVER FUNCTION TEST ABNORMAL 3 0.0001
778 DYSPHONIA 6 0.0001
779 NASAL CONGESTION 6 0.0001
780 ASCITES 3 0.0001
781 KIDNEY INFECTION 2 0.0001
782 ANXIETY 29 0.0001
783 ARTHRITIS 8 0.0001
784 PSYCHOTIC DISORDER 3 0.0001
785 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
786 ACTIVITIES OF DAILY LIVING IMPAIRED 2 0.0001
787 SINUS DISORDER 2 0.0001
788 VOMITING 47 0.0001
789 PREGNANCY 2 0.0001
790 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
791 CORONARY ARTERY DISEASE 3 0.0001
792 PRODUCT ADMINISTRATION ERROR 2 0.0001
793 PRURITUS 38 0.0001
794 ILL-DEFINED DISORDER 6 0.0001
795 INJECTION SITE RASH 3 0.0001
796 HAEMOGLOBIN DECREASED 10 0.0001
797 INJECTION SITE WARMTH 2 0.0001
798 RIB FRACTURE 2 0.0001
799 FEMUR FRACTURE 3 0.0001
800 WEIGHT DECREASED 27 0.0001
801 TOOTH LOSS 2 0.0001
802 CONSTIPATION 21 0.0001
803 PULMONARY HYPERTENSION 2 0.0001
804 POLLAKIURIA 4 0.0001
805 ABDOMINAL DISCOMFORT 16 0.0001
806 KNEE ARTHROPLASTY 2 0.0001
807 SKIN EXFOLIATION 8 0.0001
808 BRONCHITIS 7 0.0001
809 ANAEMIA 18 0.0001
810 GAIT DISTURBANCE 18 0.0001
811 CHILLS 11 0.0001
812 RETCHING 2 0.0001
813 JOINT INJURY 2 0.0001
814 BODY HEIGHT DECREASED 1 0.0001
815 MOVEMENT DISORDER 3 0.0001
816 BREAST CANCER METASTATIC 1 0.0001
817 HALLUCINATION 7 0.0001
818 PNEUMONIA 30 0.0001
819 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
820 AMNESIA 6 0.0001
821 BIPOLAR DISORDER 1 0.0001
822 SEPTIC SHOCK 4 0.0001
823 PRODUCT DOSE OMISSION 6 0.0001
824 ASPIRATION 1 0.0001
825 NAUSEA 72 0.0001
826 ANGIOEDEMA 4 0.0001
827 VISUAL ACUITY REDUCED 3 0.0001
828 OEDEMA PERIPHERAL 11 0.0001
829 FALL 30 0.0001
830 INSOMNIA 24 0.0001
831 PANCYTOPENIA 5 0.0001
832 GLOSSODYNIA 2 0.0001
833 GASTROINTESTINAL DISORDER 8 0.0001
834 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
835 CHROMATURIA 2 0.0001
836 HEART RATE IRREGULAR 2 0.0001
837 APPLICATION SITE PRURITUS 2 0.0001
838 DEPRESSION 20 0.0001
839 GASTRIC DISORDER 3 0.0001
840 FATIGUE 68 0.0001
841 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
842 CARDIAC FAILURE CONGESTIVE 7 0.0001
843 HYPOKALAEMIA 4 0.0001
844 CHEST PAIN 16 0.0001
845 NEOPLASM PROGRESSION 3 0.0001
846 HEADACHE 54 0.0001
847 DECREASED APPETITE 20 0.0001
848 HYPERKALAEMIA 3 0.0001
849 INJURY 6 0.0001
850 WEIGHT INCREASED 19 0.0001
851 BLOOD IRON DECREASED 1 0.0001
852 PULMONARY EMBOLISM 8 0.0001
853 C-REACTIVE PROTEIN INCREASED 3 0.0001
854 DRY SKIN 11 0.0001
855 PLEURAL EFFUSION 5 0.0001
856 FEELING HOT 5 0.0001
857 ENCEPHALOPATHY 2 0.0001
858 ALANINE AMINOTRANSFERASE INCREASED 5 0.0001
859 NASOPHARYNGITIS 15 0.0001
860 INJECTION SITE MASS 3 0.0001
861 AGEUSIA 2 0.0001
862 DRY EYE 4 0.0001
863 MEMORY IMPAIRMENT 11 0.0001
864 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
865 MALAISE 35 0.0001
866 RHEUMATOID ARTHRITIS 9 0.0001
867 BRAIN OEDEMA 1 0.0001
868 HAEMATEMESIS 2 0.0001
869 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
870 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
871 DEEP VEIN THROMBOSIS 5 0.0001
872 BEDRIDDEN 1 0.0001
873 DEPRESSED MOOD 4 0.0001
874 OROPHARYNGEAL PAIN 7 0.0001
875 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
876 DYSPHAGIA 7 0.0001
877 LIMB INJURY 2 0.0001
878 NEUTROPHIL COUNT DECREASED 3 0.0001
879 ACUTE HEPATIC FAILURE 1 0.0001
880 OSTEOPOROSIS 3 0.0001
881 APPLICATION SITE RASH 1 0.0001
882 VISUAL IMPAIRMENT 9 0.0001
883 DIVERTICULITIS 2 0.0001
884 COMPLETED SUICIDE 6 0.0001
885 RENAL IMPAIRMENT 6 0.0001
886 MYALGIA 12 0.0001
887 ABDOMINAL PAIN UPPER 14 0.0001
888 LABORATORY TEST ABNORMAL 2 0.0001
889 ABDOMINAL DISTENSION 7 0.0001
890 ADVERSE DRUG REACTION 6 0.0001
891 BONE LOSS 1 0.0001
892 HEPATIC FAILURE 2 0.0001
893 THERAPEUTIC RESPONSE DECREASED 4 0.0001
894 SUICIDAL IDEATION 6 0.0001
895 SKIN IRRITATION 3 0.0001
896 EPILEPSY 2 0.0001
897 NEPHROLITHIASIS 3 0.0001
898 ACUTE KIDNEY INJURY 10 0.0001
899 EMOTIONAL DISORDER 2 0.0001
900 URINARY TRACT INFECTION 11 0.0001
901 ACUTE MYELOID LEUKAEMIA 1 0.0001
902 DRUG-INDUCED LIVER INJURY 2 0.0001
903 MYOCARDIAL INFARCTION 11 0.0001
904 MIGRAINE 6 0.0001
905 RASH ERYTHEMATOUS 3 0.0001
906 HYPOTHYROIDISM 2 0.0001
907 BLOOD GLUCOSE DECREASED 3 0.0001
908 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
909 INTENTIONAL OVERDOSE 4 0.0001
910 CARDIAC FAILURE 5 0.0001
911 HIP FRACTURE 2 0.0001
912 DIARRHOEA 40 0.0001
913 LACTIC ACIDOSIS 2 0.0001
914 OFF LABEL USE 54 0.0001
915 DRY MOUTH 5 0.0001
916 BLOOD POTASSIUM INCREASED 1 0.0001
917 FOETAL EXPOSURE DURING PREGNANCY 5 0.0001
918 ASTHENIA 23 0.0001
919 CHOLELITHIASIS 2 0.0001
920 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
921 TREATMENT FAILURE 5 0.0001
922 FEBRILE NEUTROPENIA 4 0.0001
923 URINARY RETENTION 2 0.0001
924 EYE PRURITUS 2 0.0001
925 TYPE 2 DIABETES MELLITUS 2 0.0001
926 ANGER 2 0.0001
927 FLUID RETENTION 3 0.0001
928 HOSPITALISATION 9 0.0001
929 BLOOD GLUCOSE INCREASED 11 0.0001
930 INTENTIONAL PRODUCT MISUSE 5 0.0001
931 AMENORRHOEA 1 0.0001
932 DEATH 49 0.0001
933 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
934 INJECTION SITE ERYTHEMA 7 0.0001
935 PLATELET COUNT DECREASED 6 0.0001
936 ALOPECIA 11 0.0001
937 MOBILITY DECREASED 4 0.0001
938 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
939 ADVERSE EVENT 5 0.0001
940 THROMBOCYTOPENIA 6 0.0001
941 COUGH 15 0.0001
942 EYE PAIN 3 0.0001
943 INTESTINAL OBSTRUCTION 2 0.0001
944 BLOOD URINE PRESENT 1 0.0001
945 NEUTROPENIA 7 0.0001
946 BLOOD PRESSURE SYSTOLIC INCREASED 1 0.0001
947 IRRITABILITY 3 0.0000
948 THROMBOSIS 4 0.0000
949 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
950 SUICIDE ATTEMPT 3 0.0000
951 EXTRA DOSE ADMINISTERED 2 0.0000
952 BONE MARROW FAILURE 1 0.0000
953 DEVICE DISLOCATION 2 0.0000
954 MENTAL DISORDER 2 0.0000
955 MUSCULOSKELETAL STIFFNESS 4 0.0000
956 APPLICATION SITE PAIN 1 0.0000
957 LIVER DISORDER 2 0.0000
958 INFLUENZA 5 0.0000
959 INJECTION SITE PRURITUS 3 0.0000
960 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
961 HEPATIC ENZYME INCREASED 3 0.0000
962 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
963 ABDOMINAL PAIN 10 0.0000
964 RENAL DISORDER 2 0.0000
965 DISEASE PROGRESSION 5 0.0000
966 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3 0.0000
967 OCULAR HYPERAEMIA 2 0.0000
968 CEREBROVASCULAR ACCIDENT 7 0.0000
969 LUNG DISORDER 2 0.0000
970 LEUKOPENIA 2 0.0000
971 ACNE 3 0.0000
972 ABDOMINAL PAIN LOWER 1 0.0000
973 INCORRECT DOSE ADMINISTERED 9 0.0000
974 THERAPY CESSATION 2 0.0000
975 ILLNESS 4 0.0000
976 NERVOUSNESS 2 0.0000
977 HAEMORRHAGE 4 0.0000
978 RASH PRURITIC 2 0.0000
979 TREATMENT NONCOMPLIANCE 2 0.0000
980 GASTROINTESTINAL HAEMORRHAGE 3 0.0000
981 EYE IRRITATION 2 0.0000
982 DEVICE ISSUE 3 0.0000
983 RHINORRHOEA 2 0.0000
984 NEOPLASM MALIGNANT 2 0.0000
985 INJECTION SITE REACTION 2 0.0000
986 SKIN BURNING SENSATION 2 0.0000
987 ABORTION SPONTANEOUS 1 0.0000
988 DRUG DEPENDENCE 4 0.0000
989 EMOTIONAL DISTRESS 3 0.0000
990 DRUG WITHDRAWAL SYNDROME 2 0.0000
991 DRUG DOSE OMISSION 3 0.0000
992 BREAST CANCER 1 0.0000